1996-07-21 13:22:49.1181|INFO|Raw.Application.TcpServer.TcpServer|
<SB>
MSH|^~\&|SOMERIS|ABCHOSP|SOMEAPP|ABC_HOSP_DEPT_X|19960721132249|TBD|ORU^R01|2.25.118789473840885184121566552053064794139|P|2.4<R>
PID|1||ABC451094^^^ABC^MR~EPIC4485853^^^EPIC^MRN||LESTER^WILLIAM^GEOFFREY^^^^D||19340330000000|M||C|123 STREET^^CITY CITY^MO^61111^USA^L^^COUNTY||5555555555|||S||ABC451094^^^ABC^PN<R>
PV1||O|ABC RAD5^ABC RAD5 R-5005^ABC RAD5 R-5005^ABC||||D7823242^HANSON^KIMBERLY^K.^M.D.^^^^ABC^^^^HOSP|^^|^^|RAD|||||||||V56457135^^^ABC^VN||||||||||||||||||||||||||||||||V<R>
OBR||7320164^SYS|7795083176|IMG5017^5017 PET/CT FDG WHOLE BODY^UNKDEV|URGENT||19960720111518|||PSCRIB|||||^^^^ |D7823238^HUNT^APRIL^MARY^M.D.^^^^ABC|||||5017^Wholebody Petct AC NAC|19960721132249||IMG|||1^^^19960721132249^^U^^URGENT|       |||^Chest pain|D7823241^SANDERS^LISA^A.^^^M.D.|D7823232^MARKS^MICHAEL^R.^^^M.D.||PSCRIB|||||||||5017<R>
OBX|1|TX|2982846||LISA SANDERS, M.D.~~~~********FINAL REPORT********~~~ ||||||F<R>
OBX|2|TX|2982846||ACC#  Date Time  Exam~~7795083176 Jul 21 1996 01:22PM IMG5017 PET/CT FDG WHOLE BODY~~EXAMINATION:~Whole-body PET-CT~~FINDINGS:~The PET-CT scan demonstrates increased metabolic activity in the left~upper lung, suggestive of a hypermetabolic lesion. Notably, a 2.1 cm~mass is seen in the left upper lobe, exhibiting a standard uptake~value (SUV) of 6.3, which may indicate malignancy. Further, several~enlarged lymph nodes are present in the mediastinum, with prominent~uptake noted, indicating potential metastatic spread. The liver~appears normal in size and contour with no lesions identified. The~bones appear intact without any areas of abnormal hypermetabolism or~lytic lesions. Comparison with prior imaging shows no significant~interval change in the outlined findings, with the lung lesion~remaining consistent in size and metabolic activity since last~assessed.~~IMPRESSION:~This study reveals a hypermetabolic mass in the left upper lung,~along with mediastinal lymphadenopathy concerning for primary lung~malignancy and possible metastatic involvement. Monitoring~recommended in correlation with clinical findings. Further~investigation via biopsy may be required for definitive diagnosis.||||||F<R>
OBX|3|TX|2982846||Requested By: Hunt,April M. M.D.~~Dictated By: Lisa Sanders, M.D. on Jul 21 1996 01:22PM~~This document has been electronically signed by: Lisa Sanders, M.D.~on Jul 21 1996 01:22PM~ ~~~ ~~~ ||||||F<R>
OBX||RP|2982846|4|7795083176^UK^ZB||||||F<R>
<EB>